Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
Go back to Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 20.68 -1.5 (6.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.18 | 52 Week High | $42.49 | |||
| Open | $22.21 | 52 Week Low | $16.64 | |||
| Day High | $22.21 | P/E | N/A | |||
| Day Low | $20.61 | EPS | $-0.42 | |||
| Volume | 3,363,559 | |||||

